38 results
8-K
EX-4.1
ACER
Acer Therapeutics Inc.
22 Mar 23
Acer Therapeutics Announces $2.675 Million Registered Direct Offering
4:01pm
8-K
EX-4.2
ACER
Acer Therapeutics Inc.
22 Mar 23
Acer Therapeutics Announces $2.675 Million Registered Direct Offering
4:01pm
S-3
EX-4.1
ACER
Acer Therapeutics Inc.
Shelf registration
24 Nov 21
4:02pm
10-K
2019 FY
EX-4.1
ACER
Acer Therapeutics Inc.
Annual report
18 Mar 20
5:22pm
S-3
EX-4.1
ACER
Acer Therapeutics Inc.
Shelf registration
9 Nov 18
4:28pm
8-K
EX-4.1
jlk54aayh
15 May 18
Material Modifications to Rights of Security Holders
4:00pm
S-8
EX-4.1
e8rgkwy9wqsp
15 May 18
Registration of securities for employees
12:00am
8-K
EX-4.1
lyl1v
1 Sep 15
Opexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study
12:00am
8-K
EX-4.1
gsny29q5b93s5cvjh
7 Feb 13
Opexa Therapeutics, Inc. Announces Pricing of Common Stock and Warrant Offering
12:00am